Compare Stocks: CVRX, STIM, FOCL, and ZJYL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVRX CVRx	$1.58 -6.0%	$2.90	$1.50 ▼ $11.30	$42.09M	0.77	812,654 shs	398,661 shs
FOCL FocalTherics	$4.19 +1.5%	$4.56	$1.75 ▼ $6.40	$157.24M	-0.06	75,765 shs	76,262 shs
STIM Neuronetics	$2.13 -0.5%	$2.73	$0.80 ▼ $3.44	$162.30M	1.19	1.25 million shs	552,038 shs
ZJYL Jin Medical International	$2.06 -2.8%	$2.33	$1.53 ▼ $9.60	$325.88M	7.4	30,957 shs	12,075 shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVRX CVRx	0.00%	+1.94%	-44.76%	-70.90%	-82.66%
FOCL FocalTherics	0.00%	-0.24%	+0.72%	-22.84%	+418,999,900.00%
STIM Neuronetics	0.00%	-1.39%	-29.24%	+21.02%	-28.28%
ZJYL Jin Medical International	0.00%	+6.19%	0.00%	+10.75%	-77.11%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVRX CVRx	$1.58 -6.0%	$2.90	$1.50 ▼ $11.30	$42.09M	0.77	812,654 shs	398,661 shs
FOCL FocalTherics	$4.19 +1.5%	$4.56	$1.75 ▼ $6.40	$157.24M	-0.06	75,765 shs	76,262 shs
STIM Neuronetics	$2.13 -0.5%	$2.73	$0.80 ▼ $3.44	$162.30M	1.19	1.25 million shs	552,038 shs
ZJYL Jin Medical International	$2.06 -2.8%	$2.33	$1.53 ▼ $9.60	$325.88M	7.4	30,957 shs	12,075 shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVRX CVRx	0.00%	+1.94%	-44.76%	-70.90%	-82.66%
FOCL FocalTherics	0.00%	-0.24%	+0.72%	-22.84%	+418,999,900.00%
STIM Neuronetics	0.00%	-1.39%	-29.24%	+21.02%	-28.28%
ZJYL Jin Medical International	0.00%	+6.19%	0.00%	+10.75%	-77.11%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVRX CVRx	2.17	Hold	$4.30	172.15% Upside
FOCL FocalTherics	2.40	Hold	$7.75	84.96% Upside
STIM Neuronetics	2.60	Moderate Buy	$4.67	119.09% Upside
ZJYL Jin Medical International	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest CVRX, STIM, FOCL, and ZJYL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/25/2026	ZJYL Jin Medical International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
9/22/2026	CVRX CVRx	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$5.00
9/17/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.00
9/14/2026	STIM Neuronetics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/11/2026	STIM Neuronetics	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy
9/11/2026	STIM Neuronetics	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$5.00
9/9/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.00
8/25/2026	FOCL FocalTherics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$10.00
8/17/2026	FOCL FocalTherics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/17/2026	CVRX CVRx	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$13.00 ➝ $5.00
8/14/2026	FOCL FocalTherics	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$4.00

(Data available from 10/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVRX CVRx	$56.65M	0.74	N/A	N/A	$1.50 per share	1.05
FOCL FocalTherics	$70.53M	2.23	N/A	N/A	$0.52 per share	8.06
STIM Neuronetics	$149.16M	1.09	N/A	N/A	$0.38 per share	5.61
ZJYL Jin Medical International	$20.69M	15.75	$0.18 per share	11.24	$3.78 per share	0.54

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVRX CVRx	-$53.31M	-$1.98	N/A	N/A	N/A	-84.93%	-152.35%	-50.93%	11/4/2026 (Estimated)
FOCL FocalTherics	-$29.25M	-$1.03	N/A	N/A	N/A	-56.26%	-248.00%	-44.69%	N/A
STIM Neuronetics	-$39M	-$0.44	N/A	N/A	N/A	-19.62%	-125.11%	-22.15%	11/3/2026 (Estimated)
ZJYL Jin Medical International	$1.19M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest CVRX, STIM, FOCL, and ZJYL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/4/2026	Q3 2026	CVRX CVRx	-$0.49	N/A	N/A	N/A	$13.93 million	N/A
11/3/2026	Q3 2026	STIM Neuronetics	-$0.08	N/A	N/A	N/A	$40.43 million	N/A
8/14/2026	Q2 2026	FOCL FocalTherics	-$0.20	-$0.39	-$0.19	-$0.39	N/A	$13.20 million
8/11/2026	Q2 2026	STIM Neuronetics	-$0.1230	-$0.05	+$0.0730	-$0.05	$40.17 million	$41.57 million
8/6/2026	Q2 2026	CVRX CVRx	-$0.5246	-$0.53	-$0.0054	-$0.53	$15.55 million	$15.71 million
8/4/2026	Q2 2026	ZJYL Jin Medical International	N/A	-$0.01	N/A	-$0.0050	N/A	$4.46 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVRX CVRx	N/A	N/A	N/A	N/A	N/A
FOCL FocalTherics	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A
ZJYL Jin Medical International	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVRX CVRx	2.94	8.04	6.87
FOCL FocalTherics	1.79	1.60	1.38
STIM Neuronetics	2.84	1.88	1.69
ZJYL Jin Medical International	0.10	1.95	1.70

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVRX CVRx	75.27%
FOCL FocalTherics	62.74%
STIM Neuronetics	53.59%
ZJYL Jin Medical International	N/A

Insider Ownership

Company	Insider Ownership
CVRX CVRx	16.60%
FOCL FocalTherics	10.10%
STIM Neuronetics	8.40%
ZJYL Jin Medical International	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVRX CVRx	223	26.64 million	22.22 million	Optionable
FOCL FocalTherics	230	37.53 million	33.74 million	N/A
STIM Neuronetics	658	76.20 million	69.80 million	Optionable
ZJYL Jin Medical International	273	158.20 million	N/A	Not Optionable

CVRX, STIM, FOCL, and ZJYL Headlines

Recent News About These Companies

Jin Medical International (NASDAQ:ZJYL) Shares Climb 2.1% - Here's What Happened

October 6, 2026 | americanbankingnews.com

Jin Medical International Closes US$159 Million VIE Acquisition with Major Share Issuance

September 24, 2026 | tipranks.com

Jin Medical International to Acquire Control of Ginseng-Tech Assets via US$159 Million VIE Deal

September 8, 2026 | tipranks.com

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

August 27, 2026 | livemint.com

Jin Medical International Ltd. Class A

August 6, 2026 | edition.cnn.com

Jin Medical International (ZJYL) stock soars over 63% after hours: Here's what you need to know

August 5, 2026 | msn.com

Jin Medical International Completes VIE Deal and Expands Share Base in July 2026

August 4, 2026 | tipranks.com

JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results

August 4, 2026 | prnewswire.com

Jin Medical International

July 21, 2026 | fool.com

Jin Medical International Restructures Share Classes to Expand Super-Voting Control

July 20, 2026 | tipranks.com

Jin Medical International Earnings Estimates, EPS & Revenue | NASDAQ:ZJYL | Benzinga

July 12, 2026 | benzinga.com

Jin Medical International Ltd - Ordinary Shares - Class A

July 1, 2026 | money.usnews.com

Jin Medical Plans Major VIE Acquisition and Governance Restructuring Ahead of July 2026 EGM

June 29, 2026 | tipranks.com

Jin Medical International Replaces Audit Alliance With Enrome as Independent Auditor

June 4, 2026 | tipranks.com

Jin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share Split

April 10, 2026 | theglobeandmail.com

Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement

April 7, 2026 | prnewswire.com

Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative

March 11, 2026 | prnewswire.com

Jin Medical Shareholders Approve Dual-Class Structure and Conditional Reverse Splits

February 7, 2026 | theglobeandmail.com

Jin Medical CEO Fireside Chat

February 5, 2026 | prnewswire.com

Jin Medical to Host February 1 Fireside Chat as It Revamps Corporate Website

January 28, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CVRX, STIM, FOCL, and ZJYL Company Descriptions

CVRx NASDAQ:CVRX

$1.58 -0.10 (-5.95%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$1.61 +0.03 (+1.90%)

As of 10/9/2026 05:16 PM Eastern

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

FocalTherics NASDAQ:FOCL

$4.19 +0.06 (+1.45%)

As of 10/9/2026 04:00 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Neuronetics NASDAQ:STIM

$2.13 -0.01 (-0.47%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$2.16 +0.03 (+1.46%)

As of 10/9/2026 07:56 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Jin Medical International NASDAQ:ZJYL

$2.06 -0.06 (-2.83%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$2.05 -0.01 (-0.34%)

As of 10/9/2026 07:51 PM Eastern

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CVRX, STIM, FOCL, and ZJYL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CVRX, STIM, FOCL, and ZJYL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CVRX, STIM, FOCL, and ZJYL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CVRX, STIM, FOCL, and ZJYL Company Descriptions

CVRx NASDAQ:CVRX

FocalTherics NASDAQ:FOCL

Neuronetics NASDAQ:STIM

Jin Medical International NASDAQ:ZJYL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CVRX, STIM, FOCL, and ZJYL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CVRX, STIM, FOCL, and ZJYL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CVRX, STIM, FOCL, and ZJYL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CVRX, STIM, FOCL, and ZJYL Company Descriptions

CVRx NASDAQ:CVRX

FocalTherics NASDAQ:FOCL

Neuronetics NASDAQ:STIM

Jin Medical International NASDAQ:ZJYL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools